EI Innovate: genomics data to advance bioscience

About the event

This event will showcase our capabilities and expertise in genomics, bioinformatics, synthetic biology, crop phenotyping, and high-performance computing. This expertise allows us to understand complex biological systems in plants and animals and their interaction with the environment, which can help to develop solutions to industrial challenges in global food security, improving human, animal and plant health, and aid conservation.

We work with a number of academic and private organisations across the agriculture, food and health sectors, as well as charities and other organisations involved in conservation and protection of biodiversity.

This event will help you to fully understand the opportunities for collaboration with EI, and how engaging with our science and services can be of benefit to you and your organisation.

Offering talks, networking, discussion groups and tours, the event will improve awareness of the full range of our research and capabilities, and how these can be accessed.

We are also offering tours of the Earlham BIO Foundry and Genomics Pipelines facilities. Our state-of-the-art BIO Foundry provides automation to DNA assembly projects for the synthesis of molecules at the nanoscale level, while our high-throughput genomics facility hosts a number of different sequencing platforms. We embrace technology at the leading edge of innovation for development and rapid release to the bioscience community.

Target audience

We welcome individuals from organisations engaged with:

• research utilising genomics, bioinformatics, high performance computing and statistics applied to biological systems;
• deploying bioinformatics, data analysis, and machine learning techniques that utilise genomics data;
• repositories of biologic materials and gene banks, botanical gardens and zoos;
• the agri-food supply chain and biotech sector;
• developing lab instrumentation, tools, products, and services for bioinformatics, genomics, and data analysis and integration;
• protection of biodiversity and conservation;
• medical diagnostic, digital healthcare, precision medicine;
• bioprospecting;
• investment, plus public funders and government bodies investing in research and innovation in life sciences and adjacent technologies.